To identify more connections between the NAFLD pathogenesis and RUNX1, and to better understand the gut–liver axis implications [23], we also studied the jejunal expression of RUNX1, certain genes involved in lipid metabolism, and TLRs. This evidence concerns the gene RUNX1 and metabolic dysfunction-associated steatotic liver disease.